Intellia Therapeutics, Inc. (NTLA) vs DENTSPLY SIRONA Inc. (XRAY)
A side-by-side comparison of Intellia Therapeutics, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
NTLA
Intellia Therapeutics, Inc.
$12.26HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
XRAY
DENTSPLY SIRONA Inc.
$8.67HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — NTLA vs XRAY
growth of $100 · dividends reinvested · last 10yNTLA -30.1% (-3.5%/yr)XRAY -83.0% (-16.2%/yr)NTLA compounded faster over this window
NTLA XRAY
NTLA vs XRAY: by the numbers
- •XRAY is the larger company ($1.74B vs $1.71B market cap).
- •Both run net losses; XRAY's is the smaller (-14.99% vs -672.16% net margin).
- •NTLA grew revenue faster over the past five years (7.31% vs 1.96% CAGR).
- •XRAY pays a dividend (3.66% yield), while NTLA has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | NTLA | XRAY |
|---|---|---|
| Forward P/E | N/A | 5.68 |
| P/S ratio | 28.79 | 0.48 |
| P/B ratio | 2.35 | 1.29 |
| EV / EBITDA | N/A | 4.46 |
| FCF yield | N/A | 8.23% |
Profitability
| Metric | NTLA | XRAY |
|---|---|---|
| Gross margin | 76.47% | 49.52% |
| Operating margin | -651.67% | 11.69% |
| Net margin | -672.16% | -14.99% |
| ROE | -54.96% | -40.41% |
| ROIC | -54.45% | 10.03% |
Dividends
| Metric | NTLA | XRAY |
|---|---|---|
| Dividend yield | N/A | 3.66% |
Growth (annualized)
| Metric | NTLA | XRAY |
|---|---|---|
| Revenue CAGR (5Y) | 7.31% | 1.96% |
| FCF CAGR (5Y) | N/A | -25.74% |
| Total return CAGR (5Y) | -38.17% | -30.33% |
Frequently asked
- Which has grown faster, NTLA or XRAY?
- Over the past five years, NTLA grew revenue faster — NTLA at a 7.31% CAGR versus XRAY at 1.96%.
- Does NTLA or XRAY pay a bigger dividend?
- XRAY pays a dividend (3.66% yield), while NTLA has no payments in the available dividend history.
- How have NTLA and XRAY total returns compared?
- Over the past 10 years, NTLA delivered -3.34% and XRAY delivered -16.27% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
DENTSPLY SIRONA dividend yieldIntellia Therapeutics ROEDENTSPLY SIRONA ROEIntellia Therapeutics operating marginDENTSPLY SIRONA operating marginIntellia Therapeutics revenue growthDENTSPLY SIRONA revenue growthIntellia Therapeutics free cash flowDENTSPLY SIRONA free cash flow
Intellia Therapeutics & DENTSPLY SIRONA appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.